Mucormycosis and its prosthodontic management: A review

Rohit B. Patil, A. Chandak, U. Radke, Richa Sahai, Ruchita Kumbhare
{"title":"Mucormycosis and its prosthodontic management: A review","authors":"Rohit B. Patil, A. Chandak, U. Radke, Richa Sahai, Ruchita Kumbhare","doi":"10.25259/jadpr_11_2022","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19), during the second wave in early 2021, has created disastrous chaos. Adding more burdens to such a challenging situation, mucormycosis is an angioinvasive, fulminant fungal infection has seen a sudden raise in patients with COVID-19. Mucormycosis commonly affects the patients with compromised immunity. Early diagnosis, elimination of the predisposing factor, and antifungal therapy along with surgical debridement are the key factors responsible for successful treatment and patient survival. Mucormycosis is presented by various clinical forms. This paper reviews about the clinical presentation, diagnosis, and various treatment modalities for managing mucormycosis patients.","PeriodicalId":265132,"journal":{"name":"Journal of Advances in Dental Practice and Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Dental Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/jadpr_11_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Coronavirus disease 2019 (COVID-19), during the second wave in early 2021, has created disastrous chaos. Adding more burdens to such a challenging situation, mucormycosis is an angioinvasive, fulminant fungal infection has seen a sudden raise in patients with COVID-19. Mucormycosis commonly affects the patients with compromised immunity. Early diagnosis, elimination of the predisposing factor, and antifungal therapy along with surgical debridement are the key factors responsible for successful treatment and patient survival. Mucormycosis is presented by various clinical forms. This paper reviews about the clinical presentation, diagnosis, and various treatment modalities for managing mucormycosis patients.
毛霉病及其修复治疗:综述
在2021年初的第二波疫情中,2019冠状病毒病(COVID-19)造成了灾难性的混乱。毛霉病是一种血管侵入性暴发性真菌感染,在COVID-19患者中突然增加,这给这种具有挑战性的情况增加了更多负担。毛霉病通常影响免疫力低下的患者。早期诊断,消除易感因素,抗真菌治疗和手术清创是成功治疗和患者生存的关键因素。毛霉病有多种临床表现。本文综述了毛霉病的临床表现、诊断和各种治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信